DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹13,034 Cr | ₹9,588 Cr | ₹8,572 Cr | ₹9,766 Cr | ₹8,104 Cr |
What is the latest Total Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹13,034 Cr |
| Mar2024 | ₹9,588 Cr |
| Mar2023 | ₹8,572 Cr |
| Mar2022 | ₹9,766 Cr |
| Mar2021 | ₹8,104 Cr |
How is Total Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,034 Cr | 35.94 | |
| Mar2024 | ₹9,588 Cr | 11.85 | |
| Mar2023 | ₹8,572 Cr | -12.22 | |
| Mar2022 | ₹9,766 Cr | 20.51 | |
| Mar2021 | ₹8,104 Cr | - | |
Compare Total Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹104,550.3 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
| MANKIND PHARMA | ₹79,364.2 Cr | -7% | -5.7% | -6.8% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -2.4% |
-2.1% |
11.5% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses